Seongsu Kang

-Research for novel transdermal delivery platform -RGD-peptide based oral delivery platform -Basic study for neurogenic inflammation in the skin and development of anti-irritants based on natural TRPV-1 antagonists -Mechanistic study for retinoid, and boosting strategy for enhanced bioavailability -Genetic analysis-based cosmetics and household product development -Aging-related basic science research -Reviewing and Planning External Open Innovation (OI)

• Lead discovery; therapeutic protein engineering - Age-related macular degeneration(AMD) (Pipeline MT912) and Glaucoma - Immunomodulation of complement system using antibody multivalency - Immunomodulation for PD-L 1 and regulatory T cell (Treg)-based autoimmune diseases • Error-prone PCR based random mutagenesis for botulinum toxin A light chain(sub-project)

Biomedical Science for cell penetrating peptide(CPP), and Electroporation Thesis : Development of enhanced intracellular delivery platforms based on electroporation and cell penetrating peptide into microalgae